Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-11

Clinical Trial Update: Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of Gerilimzumab in rheumatoid arthritis patients who failed methotrexate or TNF-alpha antagonists ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gerilimzumab (gerilimzumab)

Snippet

Sponsor: Bird Rock Bio, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: WITHDRAWN